Cost-effectiveness analysis of basal-bolus therapy of type 1 diabetes using insulin detemir plus insulin aspart versus NPH plus insulin aspart regimens

被引：0

|

作者：

Valentine, WJ

Wittrup-Jensen, KU

Palmer, AJ

Roze, S

机构：

来源：

DIABETES | 2005年 / 54卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

收藏

页码：A609 / A609

页数：1

相关论文

共 50 条

[1] Cost-effectiveness analysis of basal-bolus therapy of type 1 diabetes using insulin detemir plus insulin aspart versus NPH plus insulin aspart regimens
Valentine, WJ
Wittrup-Jensen, KU
Häuser, C
Roze, S
[J]. DIABETOLOGIA, 2005, 48 : A334 - A334
[2] A comparison of the cost-effectiveness of basal-bolus therapy of Type 1 diabetes using insulin detemir plus insulin aspart versus human insulin-based regimens
Palmer, AJ
Roze, S
Valentine, WJ
Smith, IC
Wittrup-Jensen, K
[J]. DIABETOLOGIA, 2004, 47 : A344 - A344
[3] A comparison of the cost-effectiveness for basal-bolus therapy of type 1 diabetes using insulin detemir plus insulin aspart or human insulin-based regimens
Palmer, AJ
Roze, S
Valentine, WJ
Schmidt, I
Wittrup-Jensen, KW
[J]. DIABETES, 2004, 53 : A288 - A288
[4] Comparison of the cost-effectiveness for basal-bolus therapy of type-1 diabetes using insulin detemir plus insulin aspart or human insulin-based regimens in the Netherlands
Valentine, WJ
Wittrup-Jensen, K
Palmer, AJ
Roze, S
[J]. VALUE IN HEALTH, 2005, 8 (03) : 255 - 255
[5] Cost-effectiveness analysis of basal/bolus therapy in type-1 diabetes using insulin detemir plus insulin aspart or human soluble insulin-based basal/bolus regimens in Germany
Valentine, WJ
Wittrup-Jensen, KU
Palmer, AJ
Roze, S
[J]. VALUE IN HEALTH, 2005, 8 (06) : A160 - A161
[6] Insulin analogues (insulin detemir and insulin aspart) versus traditional human insulins (NPH insulin and regular human insulin) in basal-bolus therapy for patients with Type 1 diabetes
K. Hermansen
P. Fontaine
K. K. Kukolja
V. Peterkova
G. Leth
M.-A. Gall
[J]. Diabetologia, 2004, 47 : 622 - 629
[7] Insulin analogues (insulin detemir and insulin aspart) versus traditional human insulins (NPH insulin and regular human insulin) in basal-bolus therapy for patients with Type 1 diabetes
Hermansen, K
Fontaine, P
Kukolja, KK
Peterkova, V
Leth, G
Gall, MA
[J]. DIABETOLOGIA, 2004, 47 (04) : 622 - 629
[8] Insulin detemir and insulin aspart:: a promising basal-bolus regimen for type 2 diabetes
Raslová, K
Bogoev, M
Raz, I
Leth, G
Gall, MA
Hancu, N
[J]. DIABETES RESEARCH AND CLINICAL PRACTICE, 2004, 66 (02) : 193 - 201
[9] Cost-effectiveness analyses of basal-bolus therapy of type-1 diabetes using insulin detemir plus human soluble insulin versus neutral protamine hagedorm plus human soluble insulin regimens in Germany
Valentine, WJ
Palmer, AJ
Wittrup-Jensen, KU
Roze, S
[J]. VALUE IN HEALTH, 2005, 8 (06) : A163 - A163
[10] Cost-effectiveness of insulin degludec/insulin aspart versus biphasic insulin aspart in Chinese population with type 2 diabetes
Luo, Qiong
Zhou, Li
Zhou, Naitong
Hu, Ming
[J]. FRONTIERS IN PUBLIC HEALTH, 2022, 10

← 1 2 3 4 5 →